A Cross-Sectional Study Revealed a Low Prevalence of SARS-CoV-2 Infection among Asymptomatic University Students in Tripoli, North Lebanon
Rayane Rafei,
No information about this author
Layla Tajer,
No information about this author
Dalal Nour
No information about this author
et al.
Pathogens,
Journal Year:
2024,
Volume and Issue:
13(10), P. 872 - 872
Published: Oct. 3, 2024
This
study
aimed
to
investigate
the
SARS-CoV-2
infection
prevalence
among
>18-year-old
students
in
Faculty
of
Public
Health
and
Sciences
at
Lebanese
University
Tripoli,
Northern
Lebanon,
June
2023
characterize
circulating
Omicron
subvariants.
Out
357
participants,
only
2
(0.56%)
tested
positive
by
qPCR,
corresponding
0.61%
(2/326)
asymptomatic
students.
One
case
with
a
qPCR
targeting
BA.2
variant.
These
findings
indicate
low
incidence
that
time
emphasize
interest
surveillance
Language: Английский
Neutralizing antibodies and safety of a COVID-19 vaccine against SARS-CoV-2 wild-type and Omicron variants in solid cancer patients
B. Chewaskulyong,
No information about this author
Pattarapong Satjaritanun,
No information about this author
Thanika Ketpueak
No information about this author
et al.
PLoS ONE,
Journal Year:
2024,
Volume and Issue:
19(11), P. e0310781 - e0310781
Published: Nov. 7, 2024
The
aim
of
this
study
was
to
assess
the
seroconversion
rate
and
percent
inhibition
neutralizing
antibodies
against
wild-type
Omicron
variants
SARS-CoV-2
in
patients
with
solid
cancer
who
received
two
COVID-19
vaccine
doses
by
comparing
chemotherapy
nonchemotherapy
groups.
Language: Английский